BNF for Children 2011-2012

Abbreviations and symbolsInternationally recognised units and symbols are used inthe BNF for Children where possible.ACBS Advisory Committee on Borderline Substances,see Appendix 2ACE Angiotensin-converting enzymeADHD attention deficit hyperactivity disorderAIDS Acquired immunodeficiency syndromeapprox. approximatelyAV atrioventricularBAN British Approved NameBMI body mass indexBP British Pharmacopoeia 2010, unless otherwisestatedBPC British Pharmaceutical Codex 1973 and Supplement1976, unless otherwise statedCAPD Continuous ambulatory peritoneal dialysis2 preparation in Schedule 2 of the Misuse of DrugsRegulations 2001 (and subsequent amendments).For regulations see Prescribing Controlled Drugs3 preparation in Schedule 3 of the Misuse of DrugsRegulations 2001 (and subsequent amendments).For regulations see Prescribing Controlled DrugsK preparation in Schedule 4 (Part I) of the Misuse ofDrugs Regulations 2001 (and subsequentamendments). For regulations see PrescribingControlled DrugsL preparation in Schedule 4 (Part II) of the Misuse ofDrugs Regulations 2001 (and subsequentamendments). For regulations see PrescribingControlled DrugsCHM Commission on Human MedicinesCHMP Committee for Medicinal Products for Human UseCNS central nervous systemCSM Committee on Safety of Medicines (now subsumedunder Commission on Human Medicines)d. c. direct currentDMARD Disease-modifying antirheumatic drugDPF Dental Practitioners’ Formularye/c enteric-coated (termed gastro-resistant in BP)ECG electrocardiogramEEG electro-encephalogramf/c film-coatedG6PD glucose 6-phosphate dehydrogenaseHIV Human immunodeficiency virusHRT Hormone replacement therapyi/m intramusculari/v intravenousINR international normalised ratioMAOI Monoamine-oxidase inhibitorsmax. maximumMHRA Medicines and Healthcare products RegulatoryAgencym/r modified-releaseNCL no cautionary labels, see Appendix 3NHS National Health ServiceD not prescribable under National Health Service(NHS)NICE National Institute for Health and Clinical ExcellenceNPF Nurse Prescribers’ FormularyNSAID non-steroidal anti-inflammatory drugPGD patient group directionA prescription-only medicinectrade markrINN Recommended International Non-proprietaryNameRSV respiratory syncytial viruss/c sugar-coatedSLS Selected List SchemeSMC Scottish Medicines ConsortiumSPC Summary of Product Characteristicsspp. speciesSSRI Selective serotonin reuptake inhibitorsUK United KingdomUnits for SI units see Prescription WritingWHO World Health OrganizationT limited experience of the use of this product andthe CHM requests that all suspected adversereactions should be reported, see Adverse Reactionsto DrugsU considered by the Paediatric Formulary Committeeto be less suitable for prescribing, see How to Usethe BNF for ChildrenLatin abbreviationsDirections should be in English without abbreviation.However, Latin abbreviations have been used whenprescribing. The following is a list of appropriate abbreviations.It should be noted that the English version isnot always an exact translation.a. c. = ante cibum (before food)b. d. = bis die (twice daily)o. d. = omni die (every day)o. m. = omni mane (every morning)o. n. = omni nocte (every night)p. c. = post cibum (after food)p. r. n. = pro re nata (when required)q. d. s. = quater die sumendum (to be taken four timesdaily)q. q. h. = quarta quaque hora (every four hours)stat = immediatelyt. d. s. = ter die sumendum (to be taken three times daily)t.i.d. = ter in die (three times daily)E numbersThe following is a list of common E numbers and theinactive ingredients to which they correspond.E102E104E110E123E124E127E132E142E171E172E200E211TartrazineQuinoline YellowSunset Yellow FCFAmaranthPonceau 4RErythrosine BSIndigo CarmineGreen STitanium DioxideIron oxides, ironhydroxidesSorbic AcidSodium BenzoateE223 Sodium MetabisulphiteE320 Butylated HydroxyanisoleE321 Butylated HydroxytolueneE322 LecithinsE420 SorbitolE421 MannitolE422 GlycerolE901 Beeswax (white andyellow)E1520 Propylene Glycol